Design
Review
Authors
Loading...
Requires vigilance for FK506 toxicities in practice; leaves open optimization of analogs for improved indices.
FK506 is a potent immunosuppressant that inhibits calcineurin, but its side effects have driven the search for safer analogs.
Francis J. Dumont (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: